AbbVie Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15.00B | 16.62B | 15.78B | 15.42B | 13.34B | 15.10B | 14.46B | 14.46B |
| Cost of Goods Sold | 4.22B | 4.55B | 5.30B | 4.35B | 4.00B | 4.40B | 4.21B | 4.20B |
| Gross Profit | 10.78B | 12.07B | 10.47B | 11.08B | 9.34B | 10.71B | 10.25B | 10.26B |
| R&D Expenses | 2.47B | 2.58B | 2.32B | 2.13B | 2.07B | 6.77B | 2.13B | 1.95B |
| Operating Expenses | 6.05B | 6.26B | 8.57B | 6.18B | 5.61B | 12.20B | 6.42B | 6.26B |
| Operating Income | 4.73B | 5.81B | 1.90B | 4.89B | 3.73B | -1.49B | 3.83B | 4.00B |
| Other Income / Gains | -3.69B | -3.14B | -1.19B | -3.34B | -2.07B | -779.0M | -1.75B | -1.85B |
| Net Income | 699.0M | 1.82B | 186.0M | 938.0M | 1.29B | -22.0M | 1.56B | 1.37B |
| EPS (Diluted) | 0.39 | 1.02 | 0.10 | 0.53 | 0.72 | -0.018 | 0.88 | 0.77 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.719 | 0.726 | 0.664 | 0.718 | 0.70 | 0.709 | 0.709 | 0.709 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 3.58B | 3.90B | 3.57B | 3.25B | 3.29B | 3.85B | 4.21B | 3.38B |
| Other Expenses | 0 | -217.0M | 2.68B | 799.0M | 248.0M | 1.57B | 82.0M | 937.0M |
| Cost And Expenses | 10.27B | 10.81B | 13.87B | 10.53B | 9.61B | 16.59B | 10.63B | 10.46B |
| Interest Income | 72.0M | 59.0M | 72.0M | 62.0M | 73.0M | 92.0M | 129.0M | 220.0M |
| Interest Expense | 717.0M | 714.0M | 739.0M | 740.0M | 700.0M | 702.0M | 720.0M | 726.0M |
| Depreciation And Amortization | 1.94B | 1.99B | 2.06B | 2.05B | 2.04B | 2.10B | 2.08B | 2.13B |
| Ebitda | 3.69B | 5.37B | 3.52B | 4.34B | 4.40B | 535.0M | 4.88B | 5.00B |
| Ebitdaratio | 0.246 | 0.323 | 0.223 | 0.282 | 0.33 | 0.035 | 0.338 | 0.346 |
| Operating Income Ratio | 0.316 | 0.35 | 0.121 | 0.317 | 0.28 | -0.099 | 0.265 | 0.276 |
| Income Before Tax | 1.04B | 2.67B | 714.0M | 1.55B | 1.66B | -2.27B | 2.08B | 2.15B |
| Income Before Tax Ratio | 0.069 | 0.161 | 0.045 | 0.101 | 0.124 | -0.15 | 0.144 | 0.148 |
| Income Tax Expense | 342.0M | 853.0M | 526.0M | 613.0M | 372.0M | -2.25B | 520.0M | 773.0M |
| Net Income Ratio | 0.047 | 0.109 | 0.012 | 0.061 | 0.096 | -0.001 | 0.108 | 0.095 |
| Epsdiluted | 0.39 | 1.02 | 0.099 | 0.53 | 0.72 | -0.018 | 0.88 | 0.77 |
| Weighted Average Shs Out | 1.77B | 1.78B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Weighted Average Shs Out Dil | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |